PROFESSIONAL EXPERIENCE
2011-2012
Erzurum Koprukoyu State Hospital
Department: General Medicine
2012-2017
Istanbul University Cerrahpaşa Medical Faculty
Department: Internal Medicine
06/2017-10/2017
Istanbul Gaziosmanpasa Taksim Training and Research Hospital
Department: Internal Medicine
10/2017-11/2018
Istanbul University Istanbul Medical Faculty
Department: Allergy and Immunology Fellowship
2018/2022
Istanbul University Oncology Institute
Department: Medical Oncology Fellowship
2022-2023
Tekirdag City Hospital
Department: Medical Oncology Specialist
2023-present
Istanbul Medipol University Medipol Bahcelievler Private Hospital
Department: Medical Oncology Assoc. Prof.
EDUCATION
2005-2011
Medical Education
Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey
2012-2017
Internal Medicine
Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey
2017-2018
Allergy-Immunology Fellowship
Istanbul University Istanbul Medical Faculty
Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey
2018-2022
Medical Oncology Fellowship
Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey
2022
ESMO Board Certification in Medical Oncology
10th September 2022 in Paris, France.
2023
Medical Oncology Assoc. Prof.
Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey
INTERNATIONAL CLINICAL TRIALS:
1. Astefania - ROCHE
2. PFİZER
3. RECITE - AMGEN
4. NAVIGATE - BAYER
5. RUBY - Tesaro (PRA)
6. ENGOT-ov43/GOG-3036 - MSD
7. ASTRA ZENECA
8. ROSY-O - ASTRA ZENECA
INTERNATIONAL PUBLICATIONS
I. Published journal articles indexed by SCI, SSCI, and AHCI
Weekly Paclitaxel in Classic Kaposi Sarcoma
Carboplatin Desensitization in Ovarian Carcinoma
High-Dose Chemotherapy for Ewing’s Sarcoma
Multidrug Refractory TFE3(+) Renal Cell Carcinoma
Crizotinib Efficacy in NSCLC with MET Alterations
Clinicopathological Features in ALK Mutant NSCLC
PSMA-Based Tumor Burden in Prostate Cancer
Atezolizumab in Metastatic Urothelial Carcinoma
Pulmonary Sarcomatoid Carcinoma
Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma
Atezolizumab with Chemotherapy in Small Cell Lung Cancer
FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer
Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients
Real-Life Efficacy of Osimertinib in Advanced NSCLC
ALK-Positive Cells Percentage and Alectinib Efficacy
Real-World Data on Alectinib in ALK-Positive NSCLC
Prognostic Factors in Metastatic RCC with T790M Mutation
FLOT Regimen in Metastatic Gastric Cancer
Desensitization Protocol in Lenalidomide Hypersensitivity Reactions
Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity
Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors
Subsequent Treatments in Hormone-Positive Breast Cancer Progression
Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer
Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer
Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer
Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer
Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients
Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients
Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases
FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer
Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer
Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma
Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma
Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)
Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)
Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.
Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49
Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4
Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.
Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY
Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology
Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)
Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)
Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)
Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)
Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye
Thesis:
Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)
International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)
Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination
Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study
Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer
Efficacy of temozolomide in pretreated patients with metastatic sarcoma
Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors
Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma
Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases
Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma
Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study
Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences
Mostrar más
PROFESSIONAL EXPERIENCE
2011-2012
Erzurum Koprukoyu State Hospital
Department: General Medicine
2012-2017
Istanbul University Cerrahpaşa Medical Faculty
Department: Internal Medicine
06/2017-10/2017
Istanbul Gaziosmanpasa Taksim Training and Research Hospital
Department: Internal Medicine
10/2017-11/2018
Istanbul University Istanbul Medical Faculty
Department: Allergy and Immunology Fellowship
2018/2022
Istanbul University Oncology Institute
Department: Medical Oncology Fellowship
2022-2023
Tekirdag City Hospital
Department: Medical Oncology Specialist
2023-present
Istanbul Medipol University Medipol Bahcelievler Private Hospital
Department: Medical Oncology Assoc. Prof.
EDUCATION
2005-2011
Medical Education
Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey
2012-2017
Internal Medicine
Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey
2017-2018
Allergy-Immunology Fellowship
Istanbul University Istanbul Medical Faculty
Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey
2018-2022
Medical Oncology Fellowship
Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey
2022
ESMO Board Certification in Medical Oncology
10th September 2022 in Paris, France.
2023
Medical Oncology Assoc. Prof.
Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey
INTERNATIONAL CLINICAL TRIALS:
1. Astefania - ROCHE
2. PFİZER
3. RECITE - AMGEN
4. NAVIGATE - BAYER
5. RUBY - Tesaro (PRA)
6. ENGOT-ov43/GOG-3036 - MSD
7. ASTRA ZENECA
8. ROSY-O - ASTRA ZENECA
INTERNATIONAL PUBLICATIONS
I. Published journal articles indexed by SCI, SSCI, and AHCI
Weekly Paclitaxel in Classic Kaposi Sarcoma
Carboplatin Desensitization in Ovarian Carcinoma
High-Dose Chemotherapy for Ewing’s Sarcoma
Multidrug Refractory TFE3(+) Renal Cell Carcinoma
Crizotinib Efficacy in NSCLC with MET Alterations
Clinicopathological Features in ALK Mutant NSCLC
PSMA-Based Tumor Burden in Prostate Cancer
Atezolizumab in Metastatic Urothelial Carcinoma
Pulmonary Sarcomatoid Carcinoma
Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma
Atezolizumab with Chemotherapy in Small Cell Lung Cancer
FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer
Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients
Real-Life Efficacy of Osimertinib in Advanced NSCLC
ALK-Positive Cells Percentage and Alectinib Efficacy
Real-World Data on Alectinib in ALK-Positive NSCLC
Prognostic Factors in Metastatic RCC with T790M Mutation
FLOT Regimen in Metastatic Gastric Cancer
Desensitization Protocol in Lenalidomide Hypersensitivity Reactions
Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity
Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors
Subsequent Treatments in Hormone-Positive Breast Cancer Progression
Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer
Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer
Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer
Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer
Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients
Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients
Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases
FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer
Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer
Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma
Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma
Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)
Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)
Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.
Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49
Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4
Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.
Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY
Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology
Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)
Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)
Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)
Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)
Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye
Thesis:
Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)
International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)
Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination
Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study
Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer
Efficacy of temozolomide in pretreated patients with metastatic sarcoma
Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors
Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma
Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases
Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma
Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study
Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences
Cita con el médico | precio a consultar |
Balón gástrico | $1500 - $3500 |
Terapia con yodo radiactivo | $5000 - $7000 |
Mastectomía | $5000 - $7500 |
Personal information
Title: Associate Professor
Branch: Anesthesiology
Work History:
1 Gayrettepe Florence Nightingale Hospital
Medical Specialties and Subspecialties:
1 Waist and Neck Pain
2 Cancer Pains
3 Spine Pains
4 Pain
Education
1991 - Istanbul University Cerrahpaşa Faculty of Medicine
1996 - Istanbul University Cerrahpaşa Faculty of Medicine Anesthesia and Reanimation
Specialization Training
2017 - Fellow of Interventional Pain Practice
2018- Certifield Interventional Pain Sonologist
International Articles
1 ÇÖMLEK SAVAŞ, MUTLU AYHAN, ÖZGÖNENEL EBRU, KAHRAMAN SİNAN, ÖZGÖNENEL LEVENT (2021). Atypical Fem-oral Fracture After Discontinuing Long-Term Bisphosphonate Use. Demiroğlu Bilim University Florence Nightingale
Medical Journal, 7(1), 52-56., Doi: 10.5606/fng.btd.2021.25048
2 POTTERY WAR, ORDU AYLIN (2021). Interventional Pain Management During SARS-CoV-2 Pandemic. Signa Vitae, 17(4),
178-184., doi: 10.22514/sv.2021.008
3 SAVAS COMLEK(2021). Transverse Abdominis Plane Block-Based Multimodal Analgesia Protocol Reduces Tramadol
Need After Cesarean Section. Bağcılar Medical Bulletin, 6(2), 134-141., Doi: 10.4274/BMB.galenos.2021.11.077
4 ÇÖMLEK SAVAS, SAĞLAM SEZER (2021). A New Approach for Leptomeningeal Metastases: Chemotherapy Adminis-
tered Through Lumbar Intrathecal Port. Arquivos de Neuro-Psiquiatria, Doi: 10.1590/0004-282X-ANP-2020-0554
5 SAVAS COMLEK(2021). Treatment Methods for Bone Metastasis-Induced Pain. Turkish Journal of Oncology, 36(1), 73-
78., Doi: 10.5505/tjo.2021.S1019
6 SAVAS COMLEK(2021). Ultrasound-Guided Interventions During Pregnancy for Lumbosacral Pain Unresponsive to Con-
servative Treatment: A Retrospective Review. Journal of Clinical Ultrasound, 49(1), 20-27., Doi: 10.1002/jcu.22923
7 SAVAS COMLEK(2020). Pain Control with Splanchnic Neurolysis in Pancreatic Cancer Patients Unresponsive to Celiac
Plexus Neurolysis. Journal of Pain Research, 13, 2023-2031., doi: 10.2147/JPR.S266689
8 SAVAS COMLEK(2020). Chemotherapy-Induced Pneumonitis Associated with Transient CA 15-3 Elevation. Journal of
Oncology Pharmacy Practice, 26(7), 1750-1753., Doi: 10.1177/1078155220904994
9 RAHİMİ MEHDİ, GÖĞÜZ DEMET, KAYA GÜNER, BOZKURT PERVİN, ÇÖMLEK SAVAŞ (2000). Patient Controlled Analgesia
(PCA) Application in Pediatric Patients. Ağrı, 12(1), 19-26.
10 BOZKURT PERVİN, KAYA GÜNER, TUNALI YUSUF, ÇÖMLEK SAVAŞ (1996). Bradyarrhythmia During Reperfusion in Kidney Transplantations (Case Report). Journal of the Turkish Society of Anesthesiology and Reanimation, 24(2), 92-94.
Mostrar másPersonal information
Title: Associate Professor
Branch: Anesthesiology
Work History:
1 Gayrettepe Florence Nightingale Hospital
Medical Specialties and Subspecialties:
1 Waist and Neck Pain
2 Cancer Pains
3 Spine Pains
4 Pain
Education
1991 - Istanbul University Cerrahpaşa Faculty of Medicine
1996 - Istanbul University Cerrahpaşa Faculty of Medicine Anesthesia and Reanimation
Specialization Training
2017 - Fellow of Interventional Pain Practice
2018- Certifield Interventional Pain Sonologist
International Articles
1 ÇÖMLEK SAVAŞ, MUTLU AYHAN, ÖZGÖNENEL EBRU, KAHRAMAN SİNAN, ÖZGÖNENEL LEVENT (2021). Atypical Fem-oral Fracture After Discontinuing Long-Term Bisphosphonate Use. Demiroğlu Bilim University Florence Nightingale
Medical Journal, 7(1), 52-56., Doi: 10.5606/fng.btd.2021.25048
2 POTTERY WAR, ORDU AYLIN (2021). Interventional Pain Management During SARS-CoV-2 Pandemic. Signa Vitae, 17(4),
178-184., doi: 10.22514/sv.2021.008
3 SAVAS COMLEK(2021). Transverse Abdominis Plane Block-Based Multimodal Analgesia Protocol Reduces Tramadol
Need After Cesarean Section. Bağcılar Medical Bulletin, 6(2), 134-141., Doi: 10.4274/BMB.galenos.2021.11.077
4 ÇÖMLEK SAVAS, SAĞLAM SEZER (2021). A New Approach for Leptomeningeal Metastases: Chemotherapy Adminis-
tered Through Lumbar Intrathecal Port. Arquivos de Neuro-Psiquiatria, Doi: 10.1590/0004-282X-ANP-2020-0554
5 SAVAS COMLEK(2021). Treatment Methods for Bone Metastasis-Induced Pain. Turkish Journal of Oncology, 36(1), 73-
78., Doi: 10.5505/tjo.2021.S1019
6 SAVAS COMLEK(2021). Ultrasound-Guided Interventions During Pregnancy for Lumbosacral Pain Unresponsive to Con-
servative Treatment: A Retrospective Review. Journal of Clinical Ultrasound, 49(1), 20-27., Doi: 10.1002/jcu.22923
7 SAVAS COMLEK(2020). Pain Control with Splanchnic Neurolysis in Pancreatic Cancer Patients Unresponsive to Celiac
Plexus Neurolysis. Journal of Pain Research, 13, 2023-2031., doi: 10.2147/JPR.S266689
8 SAVAS COMLEK(2020). Chemotherapy-Induced Pneumonitis Associated with Transient CA 15-3 Elevation. Journal of
Oncology Pharmacy Practice, 26(7), 1750-1753., Doi: 10.1177/1078155220904994
9 RAHİMİ MEHDİ, GÖĞÜZ DEMET, KAYA GÜNER, BOZKURT PERVİN, ÇÖMLEK SAVAŞ (2000). Patient Controlled Analgesia
(PCA) Application in Pediatric Patients. Ağrı, 12(1), 19-26.
10 BOZKURT PERVİN, KAYA GÜNER, TUNALI YUSUF, ÇÖMLEK SAVAŞ (1996). Bradyarrhythmia During Reperfusion in Kidney Transplantations (Case Report). Journal of the Turkish Society of Anesthesiology and Reanimation, 24(2), 92-94.
After graduating from Fırat University Faculty of Medicine in 2008, he worked as a physician in Şırnak Silopi Health Center No. 3 for 2 years. In 2011, he started his specialization in Manisa Celal Bayar University, Otorhinolaryngology.
He completed his specialization in ENT Diseases Specialization in 2016. In 2016, he succeeded in the written and oral exams organized by the Turkish Otorhinolaryngology and Head and Neck Surgery Association and was entitled to receive a Certificate of Proficiency.
He worked as an Ear Nose and Throat Diseases Specialist at Manisa Merkez Efendi State Hospital between 2016-2021. He has been working at Private ENTO ENT Surgical Medical Center since October 2021.
Mostrar másAfter graduating from Fırat University Faculty of Medicine in 2008, he worked as a physician in Şırnak Silopi Health Center No. 3 for 2 years. In 2011, he started his specialization in Manisa Celal Bayar University, Otorhinolaryngology.
He completed his specialization in ENT Diseases Specialization in 2016. In 2016, he succeeded in the written and oral exams organized by the Turkish Otorhinolaryngology and Head and Neck Surgery Association and was entitled to receive a Certificate of Proficiency.
He worked as an Ear Nose and Throat Diseases Specialist at Manisa Merkez Efendi State Hospital between 2016-2021. He has been working at Private ENTO ENT Surgical Medical Center since October 2021.
Cita con el médico | precio a consultar |
Levantamiento de senos | $2934.55 - $3353.77 |
Abdominoplastia | $2305.72 - $2724.94 |
Cirugía de lifting facial | $4192.21 - $5240.27 |
Education
2002 Haydarpaşa Numune Training and Research Hospital, Internal Medicine
1990 Erciyes University, Faculty of Medicine
Experience
2019 - 2019 Okan University Hospital
2018 - 2019 Ibn Sina Hospital
2003 - 2018 Pendik State Hospital
1997 - 2003 Haydarpasa Numune Hospital
1990 - 1994 Erzincan State Hospital
Istanbul Haydarpasa Numune Hospital
Kartal Health Group Presidency
Yıldırım Beyazıt Mother and Child Health Physician
Mostrar más
Education
2002 Haydarpaşa Numune Training and Research Hospital, Internal Medicine
1990 Erciyes University, Faculty of Medicine
Experience
2019 - 2019 Okan University Hospital
2018 - 2019 Ibn Sina Hospital
2003 - 2018 Pendik State Hospital
1997 - 2003 Haydarpasa Numune Hospital
1990 - 1994 Erzincan State Hospital
Istanbul Haydarpasa Numune Hospital
Kartal Health Group Presidency
Yıldırım Beyazıt Mother and Child Health Physician
Especialista en trastornos cardiovasculares. Utiliza métodos de diagnóstico avanzados.
Mostrar másEspecialista en trastornos cardiovasculares. Utiliza métodos de diagnóstico avanzados.
Se especializa en trastornos neurológicos, tratamiento y rehabilitación. Aborda la epilepsia, los trastornos del sueño, los dolores de cabeza, las enfermedades cerebrovasculares y los problemas de movimiento.
Mostrar másSe especializa en trastornos neurológicos, tratamiento y rehabilitación. Aborda la epilepsia, los trastornos del sueño, los dolores de cabeza, las enfermedades cerebrovasculares y los problemas de movimiento.
El Dr. Serdar Sürmeli se especializa en extirpar tumores de párpados, enfermedades del canal lagrimal, coriorretinitis, ruptura de retina y otros.
Mostrar másEl Dr. Serdar Sürmeli se especializa en extirpar tumores de párpados, enfermedades del canal lagrimal, coriorretinitis, ruptura de retina y otros.
El médico se especializa en el tratamiento de lesiones deportivas y relacionadas con la edad, cirugía de prótesis y ortopedia pediátrica.
Mostrar másEl médico se especializa en el tratamiento de lesiones deportivas y relacionadas con la edad, cirugía de prótesis y ortopedia pediátrica.
Médico obstetra-ginecólogo, especializado en medicina reproductiva
35 años
Médico obstetra-ginecólogo, especializado en medicina reproductiva
35 años
Cirujano, oncólogo, especialista en cirugía del aparato digestivo y oncología de la mama.
25 años
Cirujano, oncólogo, especialista en cirugía del aparato digestivo y oncología de la mama.
25 años
Urólogo, especialista en oncourología y endoscopia
20 años
Urólogo, especialista en oncourología y endoscopia
20 años
El Dr. Hasan Mirzai es un profesor médico con experiencia en cirugía cerebral y nerviosa, neurocirugía, cirugía de columna, cirugía de tumores cerebrales y cirugía cerebral pediátrica. Tiene una amplia experiencia en múltiples hospitales y es miembro de la Sociedad Mundial de la Columna Vertebral, la Asociación Médica Turca y la Asociación Turca de Neurocirugía.
Mostrar másEl Dr. Hasan Mirzai es un profesor médico con experiencia en cirugía cerebral y nerviosa, neurocirugía, cirugía de columna, cirugía de tumores cerebrales y cirugía cerebral pediátrica. Tiene una amplia experiencia en múltiples hospitales y es miembro de la Sociedad Mundial de la Columna Vertebral, la Asociación Médica Turca y la Asociación Turca de Neurocirugía.
Cita con el médico | precio a consultar |
Abdominoplastia | $6000 |
Cirugía de cáncer de mama | $7700 |
Ablación por radiofrecuencia |
El Dr. Emre Acaroglu es ortopedista y traumatólogo con más de 33 años de experiencia. Es un miembro activo de múltiples organizaciones y ha completado varios programas educativos, ha publicado artículos y libros y se ha presentado en conferencias.
Mostrar másEl Dr. Emre Acaroglu es ortopedista y traumatólogo con más de 33 años de experiencia. Es un miembro activo de múltiples organizaciones y ha completado varios programas educativos, ha publicado artículos y libros y se ha presentado en conferencias.
Cita con el médico | precio a consultar |
Abdominoplastia | $6000 |
Cirugía de cáncer de mama | $7700 |
Ablación por radiofrecuencia |
Cita con el médico | precio a consultar |
Abdominoplastia | $6000 |
Cirugía de cáncer de mama | $7700 |
Ablación por radiofrecuencia |
Cita con el médico | precio a consultar |
Abdominoplastia | $6000 |
Cirugía de cáncer de mama | $7700 |
Ablación por radiofrecuencia |
Cita con el médico | precio a consultar |
Abdominoplastia | $6000 |
Cirugía de cáncer de mama | $7700 |
Ablación por radiofrecuencia |
Cita con el médico | precio a consultar |
Abdominoplastia | $6000 |
Cirugía de cáncer de mama | $7700 |
Ablación por radiofrecuencia |
El Prof. Dr. Adem Dervişoğlu completó su educación universitaria en la Facultad de Medicina de la Universidad de Ankara y su especialización, doctorado y título de profesor en la Facultad de Medicina de Cerrahpaşa, Universidad de Estambul. También asistió a simposios avanzados y ensayos clínicos sobre tratamiento quirúrgico de la obesidad, técnicas mínimamente invasivas en cirugía visceral y cirugía endocrina respectivamente. Es miembro de la Sociedad Turca de Cirugía, Sociedad de Nutrición Parenteral Enteral Clínica, Sociedad de Hernia, Asociación de Cirugía Endocrina y Asociación de Colon y Recto.
Mostrar másEl Prof. Dr. Adem Dervişoğlu completó su educación universitaria en la Facultad de Medicina de la Universidad de Ankara y su especialización, doctorado y título de profesor en la Facultad de Medicina de Cerrahpaşa, Universidad de Estambul. También asistió a simposios avanzados y ensayos clínicos sobre tratamiento quirúrgico de la obesidad, técnicas mínimamente invasivas en cirugía visceral y cirugía endocrina respectivamente. Es miembro de la Sociedad Turca de Cirugía, Sociedad de Nutrición Parenteral Enteral Clínica, Sociedad de Hernia, Asociación de Cirugía Endocrina y Asociación de Colon y Recto.
Cita con el médico | precio a consultar |
Cirugía de cáncer de pulmón | $9000 - $13000 |
Resección transnasal de tumor | $11500 |
Banda gástrica | $2500 - $5000 |